Summary Rare diseases are just that: rare. However, when combined rare diseases affect 3.5% – 5.9% of the worldwide population, and present a growing healthcare
In Episode 67 of 17 Minutes of Science, we are joined by Dr. Gabriel Bossé. Gabriel Bossé is currently a postdoctoral fellow with Randall Peterson
Tune in to episode 64 of 17 Minutes of Science as we talk with Dr. Deborah Kurrasch about her recent paper and why she enjoys
Tune in to episode 63 as we talk with Dr. Alicia McConnell about Camp Zon, a two week research opportunity for high schoolers to get
Dr. Marius Galyan is the founder and CEO of Galyan Bio, Inc., a research company on a mission to discover new therapies for neurodegenerative diseases,
What is the microbiome? How does it help or hinder health? And, what does recent research indicate? We’ve all had that regret: “oh, I should
Join us for episode 60 of 17 Minutes of Science as we talk with Dr. Adam Saunders, one of our own scientists at InVivo Biosystems.
For episode 59 of 17 Minutes of Science we are joined by Dr. Clarice Aiello, a quantum engineer interested in how quantum physics informs biology
For episode 58 of 17 minutes of Science we are joined by Dr. Oliver Blacque, an Associate Professor in cell biology and genetics at the
Join us for episode 57 of 17 Minutes of Science as we talk with Dr. Pamela Padilla about how scientific societies can build intentional partnerships
When you have to apply for a new job, you are asked to provide a resume, CV, and a cover letter. So why then aren’t
When you have to apply for a new job, you are asked to provide a resume, CV, and a cover letter. So why then aren’t
I think the big takeaway for me is that science is relevant again! So let’s shine a light on that” – Sarah Cheesman This week,
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Learn more about our Longevity Platform and how it can benefit you by tuning into our recent webinar! Title: A Shortcut to Understanding Longevity: A
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Company Changes Operating Name to InVivo Biosystems Eugene, Ore. – March 31, 2020 – NemaMetrix is changing its operating name to InVivo Biosystems as the company
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! We are
CRISPR isn’t just a buzz word anymore, in fact the genome-editing tool is probably the single most popular biological tool and fastest growing technique in
The introduction of engineered site-specific DNA endonucleases has brought precise genome editing in many model organisms into the realm of possibility. Thanks to precise and
Dr. Janis Weeks is the first to admit her career arc has been anything but traditional. The neuroscientist turned parasite researcher and global health advocate
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.